These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 1378787)

  • 1. Secondary and tertiary prevention with calcium antagonists in coronary artery disease.
    Burkart F
    Drugs; 1992; 43 Suppl 1():37-42. PubMed ID: 1378787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of calcium antagonists in progression of arteriosclerosis. Evidence from animal experiments and clinical experience. Part II. Clinical experience with preventive effects of calcium channel blockers in atheromatous coronary artery disease.
    Just H; Frey M
    Basic Res Cardiol; 1994; 89 Suppl 1():177-84. PubMed ID: 7945172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of calcium antagonists in the treatment of myocardial ischemia.
    Follath F
    Am Heart J; 1989 Nov; 118(5 Pt 2):1093-6; discussion 1096-7. PubMed ID: 2683702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myocardial infarction beyond the 48 first hours: treatment with calcium channel antagonists].
    Delahaye F; de Gevigney G; Ovize M; Landrivon G; Rabilloud M; André-Fouët X; Delaye J
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1717-24. PubMed ID: 1304145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonists and myocardial infarction.
    Hansen JF
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):665-70. PubMed ID: 1888690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of calcium antagonists against ischaemia and reperfusion damage.
    Ferrari R; Visioli O
    Drugs; 1991; 42 Suppl 1():14-26; discussion 26-7. PubMed ID: 1718690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium antagonists during and after myocardial infarction.
    Sleight P
    Drugs; 1996 Feb; 51(2):216-25. PubMed ID: 8808164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calcium antagonists in the secondary prevention of myocardial infarction].
    Lièvre M; Nony P
    Therapie; 1993; 48 Spec No():677-83. PubMed ID: 8091354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease.
    Brogden RN; Benfield P
    Drugs; 1996 May; 51(5):792-819. PubMed ID: 8861548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What, if anything, is controversial about calcium antagonists?
    Messerli FH
    Am J Hypertens; 1996 Dec; 9(12 Pt 2):177S-181S. PubMed ID: 8968430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium antagonists in secondary prevention after myocardial infarction.
    Persson S
    Drugs; 1991; 42 Suppl 2():54-60. PubMed ID: 1718702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of calcium antagonists in ischaemic heart disease.
    Pepine CJ
    Eur Heart J; 1995 Aug; 16 Suppl H():19-24. PubMed ID: 8846801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary prevention with calcium channel-blocking drugs in patients after myocardial infarction: a critical review.
    Moss AJ
    Circulation; 1987 Jun; 75(6 Pt 2):V148-53. PubMed ID: 3552311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium antagonists and atherosclerosis protection in hypertension.
    Hernández RH; Armas-Hernández MJ; Velasco M; Israili ZH; Armas-Padilla MC
    Am J Ther; 2003; 10(6):409-14. PubMed ID: 14624278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium antagonists in the post-myocardial infarction setting.
    Bertolet BD
    Drugs Aging; 1999 Dec; 15(6):461-70. PubMed ID: 10641957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of calcium antagonist trials in acute myocardial infarction.
    Roberts R
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III41-7. PubMed ID: 2691141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary prevention after myocardial infarction: effects of beta blocking agents and calcium antagonists.
    Depelchin P; Sobolski J; Jottrand M; Flament C
    Cardiovasc Drugs Ther; 1988 May; 2(1):139-48. PubMed ID: 2908719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment after myocardial infarction].
    Beurrier D; Danchin N
    Presse Med; 1994 Feb; 23(8):380-4. PubMed ID: 7911570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-angina therapy of coronary heart disease. Mono- or combination treatment].
    Kurz T; Rauch B; Kübler W
    Z Kardiol; 1991 May; 80(5):305-16. PubMed ID: 1678565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.